Literature DB >> 32362646

Strategic planning to augment the testing capacity for COVID-19 in India.

Nivedita Gupta1, Tarun Bhatnagar2, Kiran Rade3, Manoj Murhekar2, Raman R Gangakhedkar1, Anu Nagar4.   

Abstract

Background & objectives: Nearly 5,500 tests for coronavirus disease 2019 (COVID-19) had been conducted on March 31, 2020 across the Indian Council of Medical Research (ICMR)-approved public and private laboratories in India. Given the need to rapidly increase testing coverage, we undertook an exercise to explore and quantify interventions to increase the daily real-time reverse transcription-polymerase chain reaction (qRT-PCR)-based testing capacity over the next few months. The objective of this exercise was to prepare a potential plan to scale-up COVID-19 testing in India in the public sector.
Methods: Potential increase in daily testing capacity of the existing public laboratories was calculated across the three base scenarios of shifts (9, 16 and 24 h). Additional testing capacity was added for each shift scenario based on interventions ranging from procurement of additional qRT-PCR machines, leveraging spare capacity on available qRT-PCR machines not drafted into COVID-19 testing, to in-laboratory process optimization efforts.
Results: Moving to a 24 h working model in the existing approved laboratories can enhance the daily testing capacity to 40,464 tests/day. The capacity can be further bolstered by leveraging qRT-PCR and nucleic acid amplification test (NAAT)-based machines available with the Multidisciplinary Research Units (MRUs), National AIDS Control Organisation (NACO) and National Tuberculosis Elimination Programme (NTEP). Using combination/multiplex kits, and provision of automated RNA extraction platforms at all laboratories could also optimize run time and contribute to capacity increase by 1.5-2 times. Interpretation & conclusions: Adopting these interventions could help increase public sector's daily testing capacity to nearly 100,000-120,000 tests/day. It is important to note that utilization of the scaled-up testing capacity will require deployment of additional workforce, procurement of corresponding commodities for testing and scale-up of sample collection and transportation efforts.

Entities:  

Keywords:  laboratory; real-time reverse transcription-polymerase chain reaction test; Capacity

Mesh:

Substances:

Year:  2020        PMID: 32362646      PMCID: PMC7366548          DOI: 10.4103/ijmr.IJMR_1166_20

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  5 in total

1.  The importance of intra- and inter-institutional networks for capacity building in severe acute respiratory syndrome coronavirus 2 reverse transcription polymerase chain reaction services: experience from an oncology centre in eastern India.

Authors:  Deepak Kumar Mishra; Gaurav Goel; Neeraj Arora; Shekhar Krishnan; Sanjay Bhattacharya; Purva Mathur; Kamini Walia; Mammen Chandy
Journal:  Indian J Med Microbiol       Date:  2020 Jan-Mar       Impact factor: 0.985

2.  Laboratory surveillance for SARS-CoV-2 in India: Performance of testing & descriptive epidemiology of detected COVID-19, January 22 - April 30, 2020.

Authors: 
Journal:  Indian J Med Res       Date:  2020-05       Impact factor: 2.375

3.  A novel ORF-1a based SARS-CoV-2 RT-PCR assay to resolve inconclusive samples.

Authors:  Ketki Jawade; Akhauri Yash Sinha; Sharad Bhagat; Shilpa Bhowmick; Bhagyashree Chauhan; Snehal Kaginkar; Harsha Palav; Nandini Kasarpalkar; Pratik Devadiga; Kalyani Karandikar; Sachee Agarwal; Jayanthi Shastri; Kiran Munne; Vikrant M Bhor; Smita D Mahale; Subhanjan Bhowmik; Dhanashree Jagtap; Vainav Patel
Journal:  Int J Infect Dis       Date:  2021-04-11       Impact factor: 3.623

4.  Assessment of COVID-19 Molecular Testing Capacity in Jordan: A Cross-Sectional Study at the Country Level.

Authors:  Bara'a Qaqish; Malik Sallam; Maysa Al-Khateeb; Erik Reisdorf; Azmi Mahafzah
Journal:  Diagnostics (Basel)       Date:  2022-04-06

Review 5.  A Pandemic within Other Pandemics. When a Multiple Infection of a Host Occurs: SARS-CoV-2, HIV and Mycobacterium tuberculosis.

Authors:  Carmen María González-Domenech; Isabel Pérez-Hernández; Cristina Gómez-Ayerbe; Isabel Viciana Ramos; Rosario Palacios-Muñoz; Jesús Santos
Journal:  Viruses       Date:  2021-05-17       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.